HOME › DRUGS › LEBRIKIZUMAB
ACTIVE SUBSTANCE / INN

LEBRIKIZUMAB

Brand name(s): Ebglyss
EMA LISTED
AUTHORISED
Dermatitis, Atopic
ACTIVE SUBSTANCE
Lebrikizumab
REGULATORS
EMA
SPONSORS / MAH
Almirall, S.A.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EbglyssAlmirall, S.A.Authorised16/11/2023Dermatitis, Atopic

FULL INTELLIGENCE ON LEBRIKIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →